An AI driven Genomic Profiling System and Secure Data Sharing using DLT for cancer patients

In the pharmacogenomic and theranostic approach of treating melanoma, a continuous monitoring of the disease and the mutations associated with the disease is essential. Such a monitoring system has been designed and developed based upon the concept ‘One-shot learning’, a machine learning technique adapted to work with a relatively small number of training images. The samples have been exhaustively studied through genomics, epigenomics, metagenomics and environmental genomics, finding the genetic signature behind proneness of these attributes. The mutations CDK4, CDKN2A, BRAF and KIT have been included in the analysis. The prediction accuracy of the machine is found to substantially high suggesting the device for the theranostic and pharmacogenomic strategies of controlling melanoma. A Distributed Ledger Technology (DLT) based system has been proposed for real time data sharing, training and analysis enabling hospitals and research labs to communicate with each other and conduct a cost-effective diagnostic workflow.

[1]  Damian Szklarczyk,et al.  STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets , 2018, Nucleic Acids Res..

[2]  P. K. Namboori,et al.  Evaluation of Colorectal Cancer (CRC) Epidemiology A Pharmacogenomic Approach , 2017 .

[3]  James Philbin,et al.  FaceNet: A unified embedding for face recognition and clustering , 2015, 2015 IEEE Conference on Computer Vision and Pattern Recognition (CVPR).

[4]  C. Lindskog,et al.  A pathology atlas of the human cancer transcriptome , 2017, Science.

[5]  Tsippi Iny Stein,et al.  The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence Analyses , 2016, Current protocols in bioinformatics.

[6]  Grace K. Kim,et al.  Skin cancer in asians: part 2: melanoma. , 2009, The Journal of clinical and aesthetic dermatology.

[7]  Daniel Burkhardt,et al.  Distributed Ledger , 2018, 2018 IEEE International Conference on Engineering, Technology and Innovation (ICE/ITMC).

[8]  Parvathy,et al.  ' Tumor Hypoxia Diagnosis ' using Deep CNN Learning strategy a theranostic pharmacogenomic approach , 2019 .

[9]  Thomas C. Wiegers,et al.  The Comparative Toxicogenomics Database's 10th year anniversary: update 2015 , 2014, Nucleic Acids Res..

[10]  Elizabeth M. Smigielski,et al.  dbSNP: the NCBI database of genetic variation , 2001, Nucleic Acids Res..

[11]  Huan Liu.  Feature Selection , 2010, Encyclopedia of Machine Learning.

[12]  Jun Wang,et al.  SNPnexus: assessing the functional relevance of genetic variation to facilitate the promise of precision medicine , 2018, Nucleic Acids Res..

[13]  P. K. Krishnan Namboori,et al.  Comprehensive strategy for the design of precision drugs and identification of genetic signature behind proneness of the disease—a pharmacogenomic approach , 2017, Functional & Integrative Genomics.

[14]  Ming Yang,et al.  DeepFace: Closing the Gap to Human-Level Performance in Face Verification , 2014, 2014 IEEE Conference on Computer Vision and Pattern Recognition.

[15]  Eric Y. Chuang,et al.  DBCAT: Database of CpG Islands and Analytical Tools for Identifying Comprehensive Methylation Profiles in Cancer Cells , 2011, J. Comput. Biol..

[16]  Oriol Vinyals,et al.  Matching Networks for One Shot Learning , 2016, NIPS.